Hedge Funds Are Rallying Around This Downtrodden CRO Stock

Michelle deBoer-Jones

Published onApril 29, 2025

Contract research organizations (CROs) ICON PLC (NASDAQ:ICLR) and Charles River Laboratories (NYSE:CRL) have been in the news lately due to recent interest in CROs. However, many hedge funds are holding or adding to their positions in another smaller, niche CRO: Medpace Holdings Inc (NASDAQ:MEDP). The stock has tumbled 23% over the past year, with roughly half of that coming year to date, but a long list of hedge funds are hanging on despite that.

Read hedge fund letters here

Although Vulcan Value Partners appears to have first owned Medpace in Q2 2021, it established a new position in the company during the first quarter, according to its Q1 2025 letter to investors. LVS...

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Premium Members Get EVEN MORE VALUE

Subscribe to Hedge Fund Alpha

Insider Strategies and Letters to Shareholders from the Top Hedge Funds and Maximize Your Portfolio Growth with Hedge Fund Alpha

Don’t have an account?

Join Now for Free

No card, no payment! Start your 7-day free trial!

Michelle deBoer-Jones

Michelle deBoer-Jones is editor-in-chief of Hedge Fund Alpha. She also writes comparative analyses of stocks for TipRanks and runs Providence Writing Services. Previously, she was a television news producer for eight years, producing the morning news programs for NBC affiliates in Evansville, Indiana and Huntsville, Alabama and spending a short time at the CBS affiliate in Huntsville.